In the Clinic
By Julie Grisham, MS, Science Writer/Editor | Monday, July 16, 2012
Memorial Sloan Kettering’s trial to evaluate a new therapy for patients with beta-thalassemia is the first to receive FDA approval to treat this disease with genetically engineered cells.
By Memorial Sloan Kettering | Friday, July 13, 2012
Earlier this year, a surgical team from Memorial Sloan Kettering participated in an example of international collaboration at its finest: an educational outreach mission to Costa Rica.
By Memorial Sloan Kettering | Thursday, July 12, 2012
At Memorial Sloan Kettering, an experienced team of physicians, nurses, and support staff care for children with the rare eye cancer retinoblastoma and their families.
In the O.R.
By Jim Stallard, MA, Writer/Editor | Monday, July 9, 2012
Memorial Sloan Kettering surgeons have pioneered a technique that may improve quality of life for women with early-stage gynecologic cancers.
In the Lab
By Julie Grisham, MS, Science Writer/Editor | Friday, July 6, 2012
A team of investigators from Memorial Sloan Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.
By Esther Napolitano, BS, Science Writer/Editor | Thursday, July 5, 2012
More than 2,000 patients and their guests, caregivers, and healthcare providers attended Memorial Sloan Kettering’s cancer survivorship celebrations last month.
By Memorial Sloan Kettering | Monday, July 2, 2012
Pediatric Day Hospital Medical Director Farid Boulad explains that “we’re trying to excel at caring for the entire child, physically and emotionally.”
By Memorial Sloan Kettering | Monday, June 25, 2012
Dr. Morrow, Chief of Memorial Sloan Kettering’s Breast Surgical Service, discusses how our patients with breast cancer are cared for by a true team of experts in every aspect of treatment and recovery.
By Eva Kiesler, PhD, Science Writer/Editor | Monday, June 18, 2012
Rhonda D’Agostino cares for people with life-threatening complications due to cancer or its treatment – and helped pioneer a new ICU model that trains nurse practitioners and physician assistants to deliver the highest standard of care.
By Memorial Sloan Kettering | Friday, June 15, 2012
Dr. Bains talks about how he and other internationally recognized cancer experts work together to treat patients and help them return to their everyday activities.
In the News
By Media Staff | Tuesday, June 12, 2012
The magazine’s 15th annual issue recognizes more cancer physicians from Memorial Sloan Kettering than any other hospital.
By Memorial Sloan Kettering | Thursday, June 7, 2012
Dr. Allen talks about the specialized team of cancer experts at Memorial Sloan Kettering and the long-term relationships he maintains with his patients.
By Memorial Sloan Kettering | Tuesday, June 5, 2012
Memorial Sloan Kettering and IBM have agreed to collaborate on the development of a powerful tool built upon IBM Watson to provide medical professionals with improved access to comprehensive cancer data and practices.
In the Clinic
By Media Staff | Monday, June 4, 2012
A new study confirms that female childhood cancer survivors who were treated with radiation to the chest have a high risk of developing breast cancer at a young age – a risk that is comparable to that of women who have mutations in BRCA1 or BRCA2 genes.
By Memorial Sloan Kettering | Friday, June 1, 2012
Memorial Sloan Kettering’s prostate cancer team — including Howard I. Scher, Chief of the Genitourinary Oncology Service — disagrees with new PSA screening recommendations released by government task force.